Radiopharmacy1

[WP-31-1] Making errors in Lu-177-Dota-(Tyr3)-Octreotate synthesis – still within QC specifications or not?

Katrimari Kiviluoto^1,2、Vappu Reijonen¹、Veera Ahtiainen¹ (1.Molecular Radiotherapy Unit, Helsinki University Hospital Comprehensive Cancer Center、2.HUS Pharmacy, Helsinki University Hospital)